Observed arrival · 2026-11-15
Expedita turns adverse-event reports into reviewable safety cases
A pharmacovigilance AI product that says it converts reports from calls, email, literature, and other sources into coded, E2B(R3)-ready cases for safety-team review.
- For
- Pharmacovigilance teams handling adverse-event reports
- Worth noticing
- Its synthetic Spanish call transcript maps source snippets to extracted fields and shows a proposed 15-day reporting deadline.
Field notes
The public workflow lays out six stages, from intake and validity checks through coding, assessment proposals, narrative drafting, and submission routing. Its sample is explicitly labeled synthetic and retains an original Spanish call alongside an English translation, with source snippets attached to extracted details. The page names MedDRA and WHODrug and says a safety professional reviews and signs each case; these are presented as product capabilities, not independently verified outcomes.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue